Form 4: Palantir Chief Revenue and Legal Officer Executes Pre-Planned Stock Option Exercise and Sale

Palantir Technologies' Chief Revenue and Legal Officer, Ryan D. Taylor, executed a pre-planned sale of 33,335 Class A Common Stock shares on July 1, 2025, following the exercise of vested employee stock options.

Summary

• Ryan D. Taylor, Palantir Technologies Inc.'s Chief Revenue Officer and Chief Legal Officer, engaged in a pre-planned transaction on July 1, 2025.
• The transaction involved the exercise of 33,335 vested Class A Common Stock options at an exercise price of $4.72 per share.
• Immediately following the exercise, 33,335 shares of Class A Common Stock were sold in the open market at a weighted average price of $135.3068 per share.
• The sales occurred within a price range of $135.19 to $135.66.
• These transactions were conducted pursuant to a Rule 10b5-1 trading plan established on March 12, 2025.
• Following these transactions, Ryan D. Taylor beneficially owns 363,755 Class A Common Stock shares directly.
• Additionally, 33,335 employee stock options remain beneficially owned, exercisable at $4.72, with an expiration date of June 3, 2030.

Sentiment

Score: 7

Explanation: The transaction is a routine, pre-planned insider sale under a Rule 10b5-1 plan, which typically carries a neutral to slightly positive sentiment as it reflects personal financial management rather than a reactive decision. The significant difference between the exercise price and sale price indicates the executive realized substantial gains, which could be seen as a positive reflection of the company's stock performance.

Positives

• The transaction was executed under a pre-existing Rule 10b5-1 trading plan, indicating a pre-scheduled event rather than a reactive sale, which can mitigate negative market perception.
• The sale price of $135.3068 per share is significantly higher than the exercise price of $4.72, indicating substantial unrealized gains for the executive and potentially strong stock performance for Palantir.

Negatives

• The sale of shares by a high-ranking executive, even if pre-planned, can sometimes be interpreted by the market as a lack of confidence, though this is less pronounced with 10b5-1 plans.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing, as it primarily details a past insider transaction.

Management Comments

• This transaction is part of a related series of transactions undertaken on July 1, 2025 pursuant to a preexisting Rule 10b5-1 trading plan, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), entered into on March 12, 2025.
• The Reporting Person exercised 33,335 vested Class A Common Stock options and immediately sold the shares of Class A Common Stock in the open market.
• The sales reflected in this line item were made at prices ranging from $135.19 to $135.66. The price reported above reflects the weighted average sale price of trades occurring within that price range.
• The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• The options exercised in this transaction were fully vested and exercisable as of the transaction date.
• This Form 4 has been compiled based on applicable requirements to reflect the specific transactions described herein and is not intended to disclose or describe all shares and/or other equity securities owned or beneficially held by the Reporting Person.

Industry Context

This Form 4 filing details an individual executive's stock transaction and does not provide information directly related to broader industry trends or competitive landscape. It is a routine disclosure for insider trading activities.

Stakeholder Impact

• Shareholders: The sale of shares by a key executive, even if pre-planned, could be viewed with scrutiny, but the 10b5-1 plan mitigates concerns about opportunistic selling. The high sale price relative to the exercise price might reinforce confidence in the stock's appreciation.

Next Steps

• The Reporting Person undertakes to provide full information regarding the number of shares sold at each separate sale price upon request by the SEC staff, the Issuer, or a security holder.
• For additional details regarding the Reporting Person's overall stock and equity holdings, refer to the Issuer's Proxy Statement filed on April 25, 2025.

Key Dates

Keywords

Palantir Technologies Inc., PLTR, SEC Form 4, Insider Trading, Stock Option Exercise, Stock Sale, Rule 10b5-1 Plan, Executive Compensation, Ryan D. Taylor, Chief Revenue Officer, Chief Legal Officer